This report examines how news outlets in low- and middle-income countries covered the US FDA's 2020 authorization of IQOS as a modified risk tobacco product. It highlights the differences in how media discussed IQOS as either a reduced exposure or reduced risk product.
The analysis provides insights into public health communication and the framing of tobacco harm reduction strategies in diverse media landscapes.